MORAb-003

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
01220052016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Folate receptor (FR) α expression in normal tissues is restricted to a subpopulation of epithelial cells. In contrast, FRα is… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2015
2015
PURPOSE Cancer cells are highly dependent on folate metabolism, making them susceptible to drugs that inhibit folate receptor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Because of its high mortality rate, ovarian cancer is a leading cause of death among women and a highly unmet medical need. New… (More)
Is this relevant?
2012
2012
Epithelial ovarian cancer (EOC) is the most lethal of the gynecologic malignancies, largely due to the advanced stage at… (More)
Is this relevant?
2008
2008
INTRODUCTION The in vitro and in vivo behavior of the radiolabeled monoclonal antibody MORAb-003 was investigated as a prelude to… (More)
Is this relevant?
2007
2007
The highly restricted distribution of human folate receptor-alpha (FRalpha) in normal tissues and its high expression in some… (More)
Is this relevant?
2007
2007
Morphotek Inc is developing MORAb-003, a humanized monoclonal antibody directed against folate receptor alpha, for the potential… (More)
Is this relevant?
2006
2006
5027 Background: Folate receptor alpha (FRA) is over-expressed in the majority of epithelial ovarian cancers (EOC) but largely… (More)
Is this relevant?
2006
2006
10108 Background: MORAb-003 is a therapeutic humanized antibody currently in Phase I clinical trials for advanced ovarian cancer… (More)
Is this relevant?
2005
2005
The highly restricted distribution of human folate receptor-alpha (FRα) in normal tissues and its high expression in some tumors… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?